Problems in childhood obesity

Primary Care - Clinics in Office Practice

Volumn 30, Issue 2, 2003, Pages 357-374

  Hassink, Sandra ^a,b  

^a NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHILD; CHILDHOOD DISEASE; COMORBIDITY; DISEASE COURSE; GENETIC PREDISPOSITION; HEALTH CARE PERSONNEL; HUMAN; LIFESTYLE; OBESITY; PRIORITY JOURNAL; REVIEW;

EID: 0038053205     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0095-4543(03)00014-9     Document Type: Review

References (76)

1. Strauss RS, Pollack HA. Epidemic increase in childhood overweight, 1986-1998. JAMA 2001;286(22):2845-8.
2. Freedman DS, Dietz WH, Srinivasan SR, et al. The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study. Pediatrics 1999;103(6 Pt 1):1175-82.
3. Lauer RM, Connor WE, Leaverton PE, et al. Coronary heart disease risk factors in school children: the Muscatine study. J Pediatr 1975;86(5):697-706.
4. Guo S, Beckett L, Chumlea WC, et al. Serial analysis of plasma lipids and lipoproteins from individuals 9-21 y of age. Am J Clin Nutr 1993;58(1):61-7.
5. Maffeis C, Tato L. Long-term effects of childhood obesity on morbidity and mortality. Horm Res 2001;55(Suppl 1):42-5.
6. Guo SS, Chi E, Wiemandle W, et al. Serial changes in blood pressure from childhood into young adulthood for females in relation to body mass index and maturational age. Am J Hum Biol 1998;10:589-99.
7. Pi-Sunyer FX. Medical hazards of obesity. Ann Intern Med 1993;119(7 Pt 2):655-60.
8. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. CDC growth charts: United States. Adv Data 2000;314:1-27.
9. Cole TJ, Bellizzi MC, Flegal KM, et al. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000;320(7244):1240-3.
10. Kiess W, Galler A, Reich A, et al. Clinical aspects of obesity in childhood and adolescence. Obes Rev 2001;2(1):29-36.
11. Harrison SA, Diehl AM. Fat and the liver - a molecular overview. Semin Gastrointest Dis 2002;13(1):3-16.
12. Ludwig J, Viggiano TR, McGill DB, et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980;55(7):434-8.
13. Day CP, James OF. Steatohepatitis: a tale of two "hits"? [Editorial]. Gastroenterology 1998;114(4):842-5.
14. Koteish A, Diehl AM, Animal models of steatosis. Semin Liver Dis 2001;21(1):89-104.
15. Angulo P, Keach JC, Batts KP, et al. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999;30(6):1356-62.
16. Baldridge AD, Perez-Atayde AR, Graeme-Cook F, et al. Idiopathic steatohepatitis in childhood: a multicenter retrospective study. J Pediatr 1995;127(5):700-4.
17. Vajro P, Fontanella A, Perna C, et al. Persistent hyperaminotransferasemia resolving after weight reduction in obese children. J Pediatr 1994;125(2):239-41.
18. Youssef W, McCullough AJ, Diabetes mellitus, obesity, and hepatic steatosis. Semin Gastrointest Dis 2002;13(1):17-30.
19. Marchesini G, Brizi M, Bianchi G, et al. Metformin in non-alcoholic steatohepatitis. Lancet 2001;358(9285):893-4.
20. Mallat A, Preaux AM, Blazejewski S, et al. Effect of simvastatin, an inhibitor of hydroxymethylglutaryl coenzyme A reductase, on the growth of human Ito cells. Hepatology 1994;20(6):1589-94.
21. Schechter MS. Technical report: diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics 2002;109(4):e69-79.
22. Kahn A, Mozin MJ, Rebuffat E, et al. Sleep pattern alterations and brief airway obstructions in overweight infants. Sleep 1989;12(5):430-8.
23. Silvestri JM, Weese-Mayer DE, Bass MT, et al. Polysomnography in obese children with a history of sleep-associated breathing disorders. Pediatr Pulmonol 1993;16(2):124-9.
24. de la Eva RC, Baur LA, Donaghue KC, et al. Metabolic correlates with obstructive sleep apnea in obese subjects. J Pediatr 2002;140(6):654-9.
25. Gozal D. Sleep-disordered breathing and school performance in children. Pediatrics 1998;102(3 Pt 1):616-20.
26. Greenberg GD, Watson RK, Deptula D. Neuropsychological dysfunction in sleep apnea. Sleep 1987;10(3):254-62.
27. Tal A, Leiberman A, Margulis G, et al. Ventricular dysfunction in children with obstructive sleep apnea: radionuclide assessment. Pediatr Pulmonol 1988;4(3):139-43.
28. Marcus CL, Greene MG, Carroll JL. Blood pressure in children with obstructive sleep apnea. Am J Respir Crit Care Med 1998;157(4 Pt 1):1098-103.
29. Massumi RA, Sarin RK, Pooya M, et al. Tonsillar hypertrophy, airway obstruction, alveolar hypoventilation, and cor pulmonale in twin brothers. Dis Chest 1969;55(2):110-4.
30. Kravath RE, Pollak CP, Borowiecki B, et al. Obstructive sleep apnea and death associated with surgical correction of velopharyngeal incompetence. J Pediatr 1980;96(4):645-8.
31. Clinical practice guideline: diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics 2002;109(4):704-12.
32. Rubinstein I, Colapinto N, Rotstein LE, et al. Improvement in upper airway function after weight loss in patients with obstructive sleep apnea. Am Rev Respir Dis 1988;138(5):1192-5.
33. Willi SM, Oexmann MJ, Wright NM, et al. The effects of a high-protein, low-fat, ketogenic diet on adolescents with morbid obesity: body composition, blood chemistries, and sleep abnormalities. Pediatrics 1998;101(1 Pt 1):61-7.
34. Kudoh F, Sanai A. Effect of tonsillectomy and adenoidectomy on obese children with sleep-associated breathing disorders. Acta Otolaryngol Suppl 1996;523:216-8.
35. Kelsey JL, Acheson RM, Keggi KJ. The body build of patients with slipped capital femoral epiphysis. Am J Dis Child 1972;124(2):276-81.
36. Schlesinger I, Waugh T. Slipped capital femoral epiphysis, unsolved adolescent hip disorder. Orthop Rev 1987;16(1):2-17.
37. Busch MT, Morrissy RT. Slipped capital femoral epiphysis. Orthop Clin North Am 1987;18(4):637-47.
38. Kempers MJ, Noordam C, Rouwe CW, et al. Can GnRH-agonist treatment cause slipped capital femoral epiphysis? J Pediatr Endocrinol Metab 2001;14(6):729-34.
39. Bandyopadhyay S, Teach SJ. Slipped capital femoral epiphysis in a 5 1/2-year-old obese male. Pediatr Emerg Care 1999;15(2):104-5.
40. Reynolds RA. Diagnosis and treatment of slipped capital femoral epiphysis. Curr Opin Pediatr 1999;11(1):80-3.
41. Loder RT, Greenfield ML. Clinical characteristics of children with atypical and idiopathic slipped capital femoral epiphysis: description of the age-weight test and implications for further diagnostic investigation. J Pediatr Orthop 2001;21(4):481-7.
42. Grumbach MM, Bin-Abbas BS, Kaplan SL. The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency. Horm Res 1998;49(Suppl 2):41-57.
43. Cassidy SB. Prader-Willi syndrome. Curr Probl Pediatr 1984;14(1):1-55.
44. State MW, Dykens EM. Genetics of childhood disorders: XV. Prader-Willi syndrome: genes, brain, and behavior. J Am Acad Child Adolesc Psychiatry 2000;39(6):797-800.
45. Lee S, Kozlov S, Hernandez L, et al. Expression and imprinting of MAGEL2 suggest a role in Prader-Willi syndrome and the homologous murine imprinting phenotype. Hum Mol Genet 2000;9(12):1813-9.
46. Carrel AL, Myers SE, Whitman BY, et al. Sustained benefits of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome are dose-dependent. J Pediatr Endocrinol Metab 2001;14(8):1097-105.
47. Lessell S. Pediatric pseudotumor cerebri (idiopathic intracranial hypertension). Surv Ophthalmol 1992;37(3):155-66.
48. Green M. Benign intracranial hypertension (pseudotumor cerebri). Pediatr Clin North Am 1967;14(4):819-30.
49. Palmer RF, Searles HH, Boldrey EB. Papillodema and hypoparathyroidism simulating brain tumor. J Neurosurg 1959;16(4):378-84.
50. Baker RS, Baumann RJ, Buncic JR. Idiopathic intracranial hypertension (pseudotumor cerebri) in pediatric patients. Pediatr Neurol 1989;5(1):5-11.
51. Walker AE, Adamkiewicz JJ. Pseudotumor cerebri associated with prolonged corticosteroid therapy. Reports of four cases. JAMA 1964;188:779-84.
52. Neville BG, Wilson J. Benign intracranial hypertension following corticosteroid withdrawal in childhood. BMJ 1970;3(722):554-6.
53. Huseman CA, Torkelson RD. Pseudotumor cerebri following treatment of hypothalamic and primary hypothyroidism. Am J Dis Child 1984;138(10):927-31.
54. DelGiudice GC, Scher CA, Athreya BH, et al. Pseudotumor cerebri and childhood systemic lupus erythematosus. J Rheumatol 1986;13(4):748-52.
55. Morrice G Jr, Havener WH, Kapetansky F. Vitamin A intoxication as a cause of pseudotumor cerebri. JAMA 1960;173:1802-5.
56. Roytman M, Frumkin A, Bohn TG. Pseudotumor cerebri caused by isotretinoin. Cutis 1988;42(5):399-400.
57. Baker RS, Carter D, Hendrick EB, et al. Visual loss in pseudotumor cerebri of childhood. A follow-up study. Arch Ophthalmol 1985;103(11):1681-6.
58. Newborg B. Pseudotumor cerebri treated by rice reduction diet. Arch Intern Med 1974;133(5):802-7.
59. Falkner B, Hassink S, Ross J, et al. Dysmetabolic syndrome: multiple risk factors for premature adult disease in an adolescent girl. Pediatrics 2002;110(1 Pt 1):e1-e5.
60. National Institutes of Health. National Heart, Lung, and Blood Institute. National Cholesterol Education Program. Third report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Bethesda (MD): National Institutes of Health; 2002. NIH Publications 01-3670.
61. Falkner B, Michel S. Obesity and other risk factors in children. Ethn Dis 1999;9(2):284-9.
62. Sinaiko AR, Donahue RP, Jacobs DR, et al. Relation of weight and rate of increase in weight during childhood and adolescent to body size, blood pressure, fasting insulin, and lipids in young adults. The Minneapolis Children's Blood Pressure Study. Circulation 1999;99(11):1471-6.
63. Epstein LH, McCurley J, Wing RR, et al. Five-year follow-up of family-based behavioral treatments for childhood obesity. J Consult Clin Psychol 1990;58(5):661-4.
64. Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997;336(16):1117-24.
65. Epstein LH, Valoski A, Wing RR, et al. Ten-year follow-up of behavioral, family-based treatment for obese children. JAMA 1990;264(19):2519-23.
66. Golan M, Fainaru M, Weizman A. Role of behaviour modification in the treatment of childhood obesity with the parents as the exclusive agents of change. Int J Obes Relat Metab Disord 1998;22(12):1217-24.
67. Jelalian E, Saelens BE. Empirically supported treatments in pediatric psychology: pediatric obesity. J Pediatr Psychol 1999;24(3):223-48.
68. Sinha R, Fisch G, Teague B, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002;346(11):802-10.
69. Zimmet PZ, Collins VR, Dowse GK, et al. Hyperinsulinaemia in youth is a predictor of type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1992;35(6):534-41.
70. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1999;22(Suppl 1):S5-19.
71. American Diabetes Association. Type 2 diabetes in children and adolescents. Pediatrics 2000;105(3)(Pt 1):671-80.
72. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344(18):1343-50.
73. Freemark M, Bursey D. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes. Pediatrics 2001;107(4):e55.
74. Gidding SS, Bao W, Srinivasan SR, et al. Effects of secular trends in obesity on coronary risk factors in children: the Bogalusa Heart Study. J Pediatr 1995;127(6):868-74.
75. Rocchini AP. Adolescent obesity and hypertension. Pediatr Clin North Am 1993;40(1):8192.
76. American Academy of Pediatrics. National Cholesterol Education Program. Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics 1992;89(3 Pt 2):525-84.